angiotensin ii has been researched along with norleu3-a(1-7) in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
diZerega, G; Espinoza, T; Felix, J; Maldonado, S; Roda, N; Rodgers, KE | 1 |
Bolton, L; Dizerega, G; Rodgers, K; Verco, S | 1 |
Baker, MB; Castellano, RK; Guo, L; Jarajapu, YP; Joshi, S; Li, Y; Raizada, MK; Singh, N | 1 |
Abdallah, WF; Humayun, MS; Louie, SG; Rodgers, KE; S diZerega, G; Sivok, E; Zhang, Y | 1 |
Champion, MM; Chang, M; Ding, D; Hesek, D; Lee, M; Mobashery, S; Nguyen, TT; PĂ©rez, RL; Schroeder, VA; Suckow, MA; Wolter, WR | 1 |
1 review(s) available for angiotensin ii and norleu3-a(1-7)
Article | Year |
---|---|
Accelerated healing of diabetic wounds by NorLeu(3)-angiotensin (1-7).
Topics: Angiotensin II; Animals; Clinical Trials as Topic; Diabetes Complications; Drug Evaluation, Preclinical; Humans; Peptide Fragments; Randomized Controlled Trials as Topic; Wound Healing | 2011 |
4 other study(ies) available for angiotensin ii and norleu3-a(1-7)
Article | Year |
---|---|
Acceleration of healing, reduction of fibrotic scar, and normalization of tissue architecture by an angiotensin analogue, NorLeu3-A(1-7).
Topics: Angiotensin I; Angiotensin II; Animals; Cicatrix; Female; Mice; Mice, Inbred NOD; Peptide Fragments; Rats; Rats, Sprague-Dawley; Time Factors; Wound Healing | 2003 |
ACE2/Ang-(1-7)/Mas axis stimulates vascular repair-relevant functions of CD34+ cells.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Antigens, CD34; Cell Adhesion; Cell Movement; Cell Proliferation; Diminazene; Humans; Leukocytes, Mononuclear; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Vasoconstrictor Agents; Vasodilator Agents; Wound Healing; Xanthones | 2015 |
NorLeu3A(1-7) Accelerates Clear Corneal Full Thickness Wound Healing.
Topics: Administration, Ophthalmic; Angiotensin II; Animals; Cicatrix; Cornea; Corneal Injuries; Intraocular Pressure; Microscopy, Confocal; Microscopy, Electron, Scanning; Peptide Fragments; Rabbits; Slit Lamp; Wound Healing | 2016 |
Expression of active matrix metalloproteinase-9 as a likely contributor to the clinical failure of aclerastide in treatment of diabetic foot ulcers.
Topics: Angiotensin II; Animals; Diabetic Foot; Female; Gene Expression Regulation, Enzymologic; Matrix Metalloproteinase 8; Matrix Metalloproteinase 9; Mice; Treatment Failure; Up-Regulation; Wound Healing | 2018 |